| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.35 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |